These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16478966)

  • 1. Plasmid-mediated growth hormone-releasing hormone efficacy in reducing disease associated with Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus infection.
    Thacker EL; Holtkamp DJ; Khan AS; Brown PA; Draghia-Akli R
    J Anim Sci; 2006 Mar; 84(3):733-42. PubMed ID: 16478966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs.
    Park SJ; Seo HW; Park C; Chae C
    Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus,
    Jeong J; Kang I; Kim S; Park KH; Park C; Chae C
    Can J Vet Res; 2018 Jan; 82(1):39-47. PubMed ID: 29382967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Field trial on the simultaneous vaccination against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae].
    Herbich E; Heissenberger B; Ladinig A; Griessler A; Ritzmann M; Weissenbacher-Lang C; Hennig-Pauka I
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2013; 41(5):279-88. PubMed ID: 24126996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of combined vaccination against Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus in dually infected pigs.
    Bourry O; Fablet C; Simon G; Marois-Créhan C
    Vet Microbiol; 2015 Nov; 180(3-4):230-6. PubMed ID: 26422712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge.
    Oh T; Park KH; Yang S; Jeong J; Kang I; Park C; Chae C
    BMC Vet Res; 2019 Oct; 15(1):342. PubMed ID: 31619295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vaccination on the potentiation of porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia by Mycoplasma hyopneumoniae.
    Thacker EL; Thacker BJ; Young TF; Halbur PG
    Vaccine; 2000 Jan; 18(13):1244-52. PubMed ID: 10649626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combined porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae vaccination in piglets.
    Drexler CS; Witvliet MH; Raes M; van de Laar M; Eggen AA; Thacker EL
    Vet Rec; 2010 Jan; 166(3):70-4. PubMed ID: 20081177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal vaccination strategy against Mycoplasma hyopneumoniae, porcine reproductive and respiratory syndrome virus, and porcine circovirus type 2 in case of early M. hyopneumoniae infection.
    Yang S; Oh T; Mago J; Iwakuma A; Chae C
    Vet Med Sci; 2020 Nov; 6(4):860-874. PubMed ID: 32462794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.
    Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED
    BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.
    Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C
    Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Mycoplasma hyopneumoniae vaccine on pigs naturally infected with M. hyopneumoniae and porcine reproductive and respiratory syndrome virus.
    Moreau IA; Miller GY; Bahnson PB
    Vaccine; 2004 Jun; 22(17-18):2328-33. PubMed ID: 15149792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porcine respiratory disease complex: Interaction of vaccination and porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, and Mycoplasma hyopneumoniae.
    Chae C
    Vet J; 2016 Jun; 212():1-6. PubMed ID: 27256017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a production region model to assess the efficacy of various air filtration systems for preventing airborne transmission of porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae: results from a 2-year study.
    Dee S; Otake S; Deen J
    Virus Res; 2010 Dec; 154(1-2):177-84. PubMed ID: 20667494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 2 commercial single-dose Mycoplasma hyopneumoniae vaccines and porcine reproductive and respiratory syndrome virus (PRRSV) vaccines on pigs dually infected with M. hyopneumoniae and PRRSV.
    Park C; Kang I; Seo HW; Jeong J; Choi K; Chae C
    Can J Vet Res; 2016 Apr; 80(2):112-23. PubMed ID: 27127338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs.
    Fontanella E; Ma Z; Zhang Y; de Castro AM; Shen H; Halbur PG; Opriessnig T
    Vaccine; 2017 Jan; 35(1):125-131. PubMed ID: 27876202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection of growing swine with porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae--effects on growth, serum metabolites, and insulin-like growth factor-I.
    Roberts NE; Almond GW
    Can Vet J; 2003 Jan; 44(1):31-7. PubMed ID: 12619553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.
    Michiels A; Arsenakis I; Boyen F; Krejci R; Haesebrouck F; Maes D
    BMC Vet Res; 2017 Aug; 13(1):274. PubMed ID: 28851359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant.
    Djordjevic SP; Eamens GJ; Romalis LF; Nicholls PJ; Taylor V; Chin J
    Aust Vet J; 1997 Jul; 75(7):504-11. PubMed ID: 9258425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Mycoplasma hyopneumoniae vaccination before and at weaning against experimental challenge infection in pigs.
    Arsenakis I; Panzavolta L; Michiels A; Del Pozo Sacristán R; Boyen F; Haesebrouck F; Maes D
    BMC Vet Res; 2016 Mar; 12():63. PubMed ID: 27025924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.